- Home
- Products
Piqray (Alpelisib)
Piqray (Alpelisib)
- Medicine Name: Piqray
- Generic Name: Alpelisib
- Dosage Form & Strength: Tablets – 50 mg, 150 mg, 200 mg
- Manufactured By: Novartis Pharmaceuticals
Piqray is a PI3K-alpha-specific kinase inhibitor used in combination with Fulvestrant to treat:
- Postmenopausal women and men
- With HR-positive, HER2-negative, PIK3CA-mutated, advanced or metastatic breast cancer
- Whose disease has progressed after endocrine therapy
Recommended Dosage:
- 300 mg orally once daily (2 × 150 mg tablets) with food
- Fulvestrant to be administered per standard protocol (500 mg on Day 1, Day 15, Day 29, then monthly)
- Continue treatment until disease progression or unacceptable toxicity
- Do not crush or chew tablets. If a dose is missed by more than 9 hours or vomiting occurs, skip and resume the next day
Severe Allergic Reactions: Including anaphylaxis. Discontinue immediately if symptoms appear
Cutaneous Reactions: Rare but serious conditions such as SJS, TEN, and DRESS have been reported
Hyperglycemia Risk: Monitor FPG and HbA1c before starting and regularly thereafter. Manage proactively
Pneumonitis/ILD: Discontinue permanently if confirmed
Gastrointestinal Toxicity: Diarrhea and colitis-like symptoms may lead to dehydration or kidney issues
Pregnancy Risk: Can cause fetal harm. Use contraception during treatment and for 7 days post-treatment
Required Documents to Import to India:
- Valid medical prescription
- Diagnostic test reports
- Government-issued photo ID
Order Confirmation:
- Orders are confirmed post-document verification and receipt of any required import permits
Availability: Piqray is available in India through Global Rare Meds across Mumbai, Pune, Delhi, Kolkata, Hyderabad, Ahmedabad, Bangalore, and other metro cities. Export available to eligible countries through the Named Patient Program.
To Order or Enquire:
- 📞 Call / WhatsApp: +91-99675 15602
- 📧 Email: info@globalraremeds.com
Global Rare Meds sources Piqray from certified and reliable suppliers in USA, Europe, Canada, and Australia. Every order is dispensed against a valid prescription, reviewed by licensed pharmacists, and shipped securely from our fulfillment center in Ambernath, Thane District.
We ensure legal compliance, quality assurance, and timely delivery across India and internationally.
What is the generic name of Piqray®?
Alpelisib
Who manufactures Piqray®?
Novartis Pharmaceuticals Corporation
Is Piqray® FDA-approved?
Yes, FDA approval was granted on May 24, 2019
What dosage strengths are available?
50 mg, 150 mg, and 200 mg film-coated tablets
What are common side effects?
Rash, nausea, diarrhea, mouth sores, appetite loss, fatigue, weight loss, hair thinning, vomiting, altered lab parameters
What is the price of Piqray® in India?
Pricing varies. For current quotes, contact us via WhatsApp +91-99675 15602 or email info@globalraremeds.com
How should Piqray® be stored?
Store at 20°C to 25°C (68°F to 77°F). Excursions permitted between 15°C and 30°C
Can I order Piqray® online in India?
Yes. We legally facilitate access under India’s Named Patient Import Program
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
